about
Splicing alterations in human renal allografts: detection of a new splice variant of protein kinase Par1/Emk1 whose expression is associated with an increase of inflammation in protocol biopsies of transplanted patientsChronic Kidney Disease is associated with an increase of Intimal Dendritic cells in a comparative autopsy study.Online Haemodiafiltration Improves Inflammatory State in Dialysis Patients: A Longitudinal Study.Datasets for the validation of the "in vivo" siRNA-silencing of CD40 and for the detection of new markers of atherosclerosis progression in ApoE-deficient mice.Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients.Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.Histologic findings in protocol biopsies performed in stable renal allografts under different immunosuppressive schedules.Baseline immunosuppression is associated with histological findings in early protocol biopsies.Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.Glomerular size in early protocol biopsies is associated with graft outcome.Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.Artificial Intelligence for the Artificial Kidney: Pointers to the Future of a Personalized Hemodialysis Therapy.Relationship between subclinical rejection and genotype, renal messenger RNA, and plasma protein transforming growth factor-beta1 levels.Association of ANRIL gene polymorphisms with major adverse cardiovascular events in hemodialysis patients.Corrigendum to 'Association of ANRIL gene polymorphisms with major adverse cardiovascular events in hemodialysis patients' [Clinica Chimica Acta (2017) 61-67].Influence of hematopoietic microchimerism in organ tolerance after kidney or heart transplantation.Effect of ETA/ETB receptor antagonist administration on iNOS gene expression in a rat renal transplantation modelAn Exonic Switch Regulates Differential Accession of microRNAs to the Cd34 Transcript in Atherosclerosis ProgressionProgress in the Development and Challenges for the Use of Artificial Kidneys and Wearable Dialysis DevicesArtificial Intelligence and Dialysisminating the Path of Atherosclerosis Progression: Chaos Theory Suggests a Role for Repeats in the Development of Atherosclerotic Vascular DiseaseEarly Subclinical Rejection as a Risk Factor for Late Chronic Humoral RejectionPretransplant Low CD3+CD25high Cell Counts or a Low CD3+CD25high/CD3+HLA-DR+ Ratio Are Associated With an Increased Risk to Acute Renal Allograft RejectionImmunephenotype of Glomerular and Interstitial Infiltrating Cells in Protocol Renal Allograft Biopsies and Histological DiagnosisSubclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft LossSubclinical rejection impairs glomerular adaptation after renal transplantationAngiotensin Converting Enzyme Genotype and Chronic Allograft Nephropathy in Protocol BiopsiesTGF-β1 gene expression in protocol biopsies from patients with stable renal allograft functionInfluence of nephron mass in development of chronic renal failure after prolonged warm renal ischemiaPROTOCOL RENAL ALLOGRAFT BIOPSIES AND THE DESIGN OF CLINICAL TRIALS AIMED TO PREVENT OR TREAT CHRONIC ALLOGRAFT NEPHROPATHY1Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantationThe renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate—cure with ketoconazole and allopurinolLOW-DOSE CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH SUBOPTIMAL RENAL FUNCTION1,2Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graftRECIPIENT BODY SURFACE AREA AS A PREDICTOR OF POSTTRANSPLANT RENAL ALLOGRAFT EVOLUTION1Unveiling ncRNA regulatory axes in atherosclerosis progressionIntegrated miRNA/mRNA Counter-Expression Analysis Highlights Oxidative Stress-Related Genes CCR7 and FOXO1 as Blood Markers of Coronary Arterial DiseaseThe double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE -/- mice
P50
Q28263039-2E73F820-A928-43B4-86B6-B0D93ACD607AQ35312524-3D17DFA6-2295-4102-A75B-3372E581BEA5Q36174924-3CE50F2F-7F39-47A5-A33C-25D63E821E35Q37453150-123F33C0-E3A0-4657-90E1-FB288339E6ECQ42166284-DF668CDA-587A-4394-8751-C4CAB6145219Q43963190-F5FF4A33-7AC9-4A5D-A88B-7301BC75E5CDQ44577525-5DC75C59-5503-45AD-AFB8-268BE7B8D6C1Q45103459-EF02918B-441D-49BF-A155-9127595C1E21Q46632322-EA9AE16E-AF3F-44F7-8C26-7A177F40D90BQ46816094-F11F4EBB-DA5C-42A2-BD6A-72039A3934A0Q47993155-CE3A2691-D9D9-40CE-BDCE-C8580171541BQ53824686-846250E8-B6F8-4081-B62E-29D56B4C17B5Q54599513-9FF11B88-888E-49E9-9F7E-469E8BB3294BQ54659071-F04DF8C0-53C3-4BC9-8685-BECC427BA344Q54704147-A2C191A2-61A0-4F26-A5D0-594AA3E3D2D9Q54756116-696C0B6E-C368-41FE-B141-0E5786DB2B9DQ60484123-75A1ED2E-8390-416D-8E24-6A4B50DFEE5AQ61812386-1F8BE518-6C1C-4BAF-9383-A996E3272B28Q62489895-22B5CD52-A477-4F71-AC1E-60447B7978D1Q62489901-7A71905A-8810-42BF-969B-9B9E6005308FQ62619819-5188F690-3F1B-436E-B9C6-E35E1A3DAB59Q62619825-FF0D54EF-5BC4-4E31-80C2-538E24B2B421Q62619827-CC5C5734-765F-4AE1-8FE5-C150A709952BQ62619829-D3E53D95-883D-42F0-A971-A1B8D0F14A18Q62619830-0264ED22-342D-4A27-8CEA-E8B269348BD3Q62619831-06E77140-940E-4F3B-9AC0-EDDCA8B5B0B9Q62619832-5D0DFAF8-56F0-4EF0-A8EB-40DF0FC89ABEQ62619842-13E889E4-4A76-4FEA-B1B1-4E676DDCC2ACQ62619844-7CE55ABB-DF75-4B28-B7F8-64057E210E0BQ62619846-D0CB8D4B-412B-43B2-ACCB-215A5A662BDAQ62619853-02C2928B-C46B-40BC-8AA9-3452B1CEAEFCQ62619855-76928BED-E92A-495E-8F74-DB25ECB9BD55Q62619859-F9C5BC6F-D1DB-4F7F-A64B-4E7738D394CCQ62619862-0B280F20-194A-4C8A-BFFF-1C22682713C0Q62619864-7AC3E48B-E6FA-4167-9AE8-E55357A13457Q89490386-21C4A7D5-F2F0-4936-A747-08932E515430Q90363055-078C599B-510B-400A-9699-688F615819D3Q92340246-28F1CB23-F2AE-489C-906D-089CEC9F867B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Miguel Hueso
@ast
Miguel Hueso
@en
Miguel Hueso
@es
Miguel Hueso
@nl
Miguel Hueso
@sl
type
label
Miguel Hueso
@ast
Miguel Hueso
@en
Miguel Hueso
@es
Miguel Hueso
@nl
Miguel Hueso
@sl
prefLabel
Miguel Hueso
@ast
Miguel Hueso
@en
Miguel Hueso
@es
Miguel Hueso
@nl
Miguel Hueso
@sl
P1053
G-5647-2016
P106
P1153
6602166995
P21
P31
P3829
P496
0000-0002-1824-9141